Robert C Salisbury's Net Worth
-$46.6 Thousand
Who is Robert C Salisbury?
Robert C Salisbury does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ENZON PHARMACEUTICALS INC, and VIRAGEN INC.
SEC CIK
Robert C Salisbury's CIK is 0001185468
Past Insider Trading and Trends
2008 was Robert C Salisbury's most active year for acquiring shares with 16 total transactions. Robert C Salisbury's most active month to acquire stocks was the month of June. 2008 was Robert C Salisbury's most active year for disposing of shares, totalling 4 transactions. Robert C Salisbury's most active month to dispose stocks was the month of June. 2004 saw Robert C Salisbury paying a total of $19,250.00 for 350,000 shares, this is the most they've acquired in one year. In 2008 Robert C Salisbury cashed out on 9,562 shares for a total of $13,097.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ENZON PHARMACEUTICALS INC (ENZN) Snapshot price: $0.1601
InvestorRobert C Salisbury owns 67,707 units of Common Stock which is worth $10,839.89. In the year 2005 Robert C Salisbury filed a total of 20 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +18.71% | 10.67K |
—
|
—
| 67.71K |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +14.87% | 7.38K |
—
|
—
| 57.04K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +25.90% | 10.22K |
—
|
—
| 49.66K |
Jul 1 - Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +12.17% | 4.28K |
—
|
—
| 39.44K |
Jul 2 - Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4/A
| +39.74% | 10K |
$3.22 | $32,210.74 | 35.16K |
Nov 13
| |||
Form 4
| +7.71% | 1.94K |
$3.23 | $6,015.74 | 35.16K |
Nov 13
| |||
Form 4
| +173.13% | 15.95K |
—
|
—
| 25.16K |
Jul 1 - Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +34.44% | 2.36K |
—
|
—
| 9.21K |
Jul 1 - Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +22.42% | 1.25K |
—
|
—
| 6.85K |
Jul 1 - Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +179.85% | 3.6K |
—
|
—
| 5.6K |
May 12
| |||
| No matching records found | |||||||||
VIRAGEN INC No price found
President & CEORobert C Salisbury owns 205,000 units of Common Stock.acquired a total of 175,000 shares in VIRAGEN INC at a cost of $19,250.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 4
| +583.33% | 175K |
$0.11 | $19,250.00 | 205K |
Jan 2
| |||
| No matching records found | |||||||||